Institutional Ownership Relay Therapeutics, Inc. (RLAY)
This table provides information about the institutional ownership of Relay Therapeutics, Inc. (RLAY). We have compiled data on the 222 institutions that hold shares in the stock, with a total of 163 Million shares, which have been reported (via 13F filing form) to have a value of $607 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Sb Investment Advisers (Uk) LTD
London, X0 |
May 15, 2025 Q1 2025 |
27,904,963
shares
|
$104 Million
0.67% of portfolio
|
Q3 2020
New holding
|
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
12,105,420
shares
|
$44.9 Million
0.0% of portfolio
|
Q1 2025
Reduced 19.46%
|
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Jul 21, 2025 Q1 2025 |
10,827,067
shares
|
$40.2 Million
0.07% of portfolio
|
Q1 2025
Added 579.77%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
10,542,667
shares
|
$39.1 Million
0.0% of portfolio
|
Q2 2024
Added 7.62%
|
|
|
Casdin Capital, LLC
New York, NY |
May 15, 2025 Q1 2025 |
9,098,574
shares
|
$33.8 Million
2.79% of portfolio
|
Q1 2025
Added 1.68%
|
|
|
Tang Capital Management LLC
San Diego, CA |
May 15, 2025 Q1 2025 |
8,068,058
shares
|
$29.9 Million
1.37% of portfolio
|
Q4 2024
Added 126.12%
|
|
|
Bellevue Group Ag
Kuesnacht, V8 |
May 14, 2025 Q1 2025 |
7,377,292
shares
|
$27.4 Million
0.45% of portfolio
|
Q4 2024
Added 0.0%
|
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
5,159,192
shares
|
$19.1 Million
0.0% of portfolio
|
Q1 2025
Reduced 2.28%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
4,909,771
shares
|
$18.2 Million
0.0% of portfolio
|
Q1 2025
Reduced 1.38%
|
|
|
Nextech Invest, Ltd.
Zurich, V8 |
May 15, 2025 Q1 2025 |
3,846,409
shares
|
$14.3 Million
2.34% of portfolio
|
Q1 2025
New holding
|
|
|
Nextech Invest Ag
|
Feb 14, 2025 Q4 2024 |
3,846,409
shares
|
$14.3 Million
2.95% of portfolio
|
Q1 2024
Added 185.68%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 14, 2025 Q1 2025 |
3,477,791
shares
|
$12.9 Million
0.0% of portfolio
|
Q1 2025
Added 4.7%
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
3,070,118
shares
|
$11.4 Million
0.0% of portfolio
|
Q1 2025
Added 1.32%
|
|
|
Kynam Capital Management, LP
Princeton, NJ |
May 15, 2025 Q1 2025 |
3,063,292
shares
|
$11.4 Million
0.68% of portfolio
|
Q1 2025
Added 206.33%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
May 15, 2025 Q1 2025 |
2,942,875
shares
|
$10.9 Million
0.0% of portfolio
|
Q1 2025
Added 14.58%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
May 13, 2025 Q1 2025 |
2,799,091
shares
|
$10.4 Million
0.0% of portfolio
|
Q1 2025
Reduced 5.6%
|
|
|
Eventide Asset Management, LLC
Boston, MA |
May 15, 2025 Q1 2025 |
2,682,083
shares
|
$9.95 Million
0.15% of portfolio
|
Q3 2024
New holding
|
|
|
Bio Impact Capital LLC
Cambridge, MA |
May 15, 2025 Q1 2025 |
2,295,924
shares
|
$8.52 Million
1.11% of portfolio
|
Q1 2025
Added 1.19%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 14, 2025 Q1 2025 |
2,276,110
shares
|
$8.44 Million
0.01% of portfolio
|
Q1 2025
Added 46.92%
|
|
|
Finepoint Capital LP
Boston, MA |
May 14, 2025 Q1 2025 |
2,117,646
shares
|
$7.86 Million
0.59% of portfolio
|
Q1 2025
Reduced 2.67%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Jun 26, 2025 Q1 2025 |
2,077,995
shares
|
$7.71 Million
0.0% of portfolio
|
Q1 2025
Reduced 23.21%
|
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
1,593,186
shares
|
$5.91 Million
0.0% of portfolio
|
Q1 2025
Added 22.48%
|
|
|
Alphabet Inc.
Mountain View, CA |
May 01, 2025 Q1 2025 |
1,568,753
shares
|
$5.82 Million
0.37% of portfolio
|
Q1 2022
Added 0.29%
|
|
|
Woodline Partners LP
San Francisco, CA |
May 15, 2025 Q1 2025 |
1,518,561
shares
|
$5.63 Million
0.03% of portfolio
|
Q1 2025
Added 448.41%
|
|
|
Baker Bros. Advisors LP
New York, NY |
May 15, 2025 Q1 2025 |
1,160,117
shares
|
$4.3 Million
0.04% of portfolio
|
Q2 2023
Added 308.49%
|